Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
Eva Sum(Roche (Switzerland)), Pablo Umaña(Zurich Insurance Group (Switzerland))
Cited by 62
Related Papers
The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation
|Journal for ImmunoTherapy of Cancer|2022|24